التفاصيل البيبلوغرافية
| العنوان: |
Disseminated cryptococcosis, invasive aspergillosis, and mucormycosis in a patient treated with alemtuzumab for chronic lymphocytic leukaemia. |
| المؤلفون: |
Henn, Aurélia1 (AUTHOR) aurelia.henn@gmail.com, Mellon, Guillaume1 (AUTHOR), Henry, Benoît1 (AUTHOR), Roos-Weil, Damien2 (AUTHOR), Jauréguiberry, Stéphane1 (AUTHOR), Mordant, Pierre3 (AUTHOR), Fekkar, Arnaud4 (AUTHOR), Caumes, Eric1 (AUTHOR) |
| المصدر: |
Scandinavian Journal of Infectious Diseases. Mar2014, Vol. 46 Issue 3, p231-234. 4p. |
| مصطلحات موضوعية: |
*OLDER men, *ALEMTUZUMAB, *CHRONIC lymphocytic leukemia, *MUCORMYCOSIS, *IMMUNOCOMPROMISED patients, *MYCOSES, *CANCER risk factors, *DISEASE risk factors, *DISEASES in older people |
| مستخلص: |
We report the case of a 42-y-old man treated with alemtuzumab for chronic lymphocytic leukaemia, who developed 3 successive deep fungal infections. Despite being treated with liposomal amphotericin B and 5-flucytosine for disseminated cryptococcosis, he developed pulmonary invasive aspergillosis, followed by pulmonary mucormycosis. Several deep fungal infections may occur in association in an immunocompromised host after treatment with alemtuzumab. [ABSTRACT FROM AUTHOR] |
| قاعدة البيانات: |
Academic Search Index |
